Donna T Decosta, MD | |
7253 Ambassador Rd, Baltimore, MD 21244-2710 | |
(443) 436-1151 | |
(443) 436-1256 |
Full Name | Donna T Decosta |
---|---|
Gender | Female |
Speciality | Diagnostic Radiology |
Experience | 34 Years |
Location | 7253 Ambassador Rd, Baltimore, Maryland |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073540662 | NPI | - | NPPES |
366721900 | Medicaid | MD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | D0047641 (Maryland) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Advanced Radiology Pa | 1254327950 | 135 |
News Archive
A new way of understanding autistic disorders, incorporating both psychological and biological factors, could lead to the conditions being picked up earlier, research from UNSW has found.
SCIENTISTS at the University of Huddersfield are pioneering the use of a special gel that is ideal for administering medication to young children and others - including the elderly - who have difficulty swallowing pills and capsules. Unlike purely liquid medicines, the gel delays the release of the drug, so that it has maximum effect.
The use of chemotherapy following surgery reduces the risk of death from operable pancreatic cancer by around 30 per cent, says new research published in the British Journal of Cancer.
Roche (Basel) and Mirus Bio Corporation (Madison, WI, USA) announced today that they have entered into a definitive agreement under which Roche will acquire Mirus Bio Corporation, a privately-owned US company based in Madison, Wisconsin, that focuses on the discovery and development of innovative nucleic acid based technologies, including a proprietary RNAi (Ribonucleic Acid interference) delivery platform.
Eli Lilly and Co and Boehringer Ingelheim have announced that the European Commission has approved the use of Cymbalta (duloxetine) for the treatment of Generalised Anxiety Disorder (GAD).
› Verified 4 days ago
Entity Name | Advanced Radiology Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932167178 PECOS PAC ID: 1254327950 Enrollment ID: O20040420001334 |
News Archive
A new way of understanding autistic disorders, incorporating both psychological and biological factors, could lead to the conditions being picked up earlier, research from UNSW has found.
SCIENTISTS at the University of Huddersfield are pioneering the use of a special gel that is ideal for administering medication to young children and others - including the elderly - who have difficulty swallowing pills and capsules. Unlike purely liquid medicines, the gel delays the release of the drug, so that it has maximum effect.
The use of chemotherapy following surgery reduces the risk of death from operable pancreatic cancer by around 30 per cent, says new research published in the British Journal of Cancer.
Roche (Basel) and Mirus Bio Corporation (Madison, WI, USA) announced today that they have entered into a definitive agreement under which Roche will acquire Mirus Bio Corporation, a privately-owned US company based in Madison, Wisconsin, that focuses on the discovery and development of innovative nucleic acid based technologies, including a proprietary RNAi (Ribonucleic Acid interference) delivery platform.
Eli Lilly and Co and Boehringer Ingelheim have announced that the European Commission has approved the use of Cymbalta (duloxetine) for the treatment of Generalised Anxiety Disorder (GAD).
› Verified 4 days ago
Entity Name | University Of Maryland Diagnostic Radiology, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467996959 PECOS PAC ID: 0345513248 Enrollment ID: O20170828004107 |
News Archive
A new way of understanding autistic disorders, incorporating both psychological and biological factors, could lead to the conditions being picked up earlier, research from UNSW has found.
SCIENTISTS at the University of Huddersfield are pioneering the use of a special gel that is ideal for administering medication to young children and others - including the elderly - who have difficulty swallowing pills and capsules. Unlike purely liquid medicines, the gel delays the release of the drug, so that it has maximum effect.
The use of chemotherapy following surgery reduces the risk of death from operable pancreatic cancer by around 30 per cent, says new research published in the British Journal of Cancer.
Roche (Basel) and Mirus Bio Corporation (Madison, WI, USA) announced today that they have entered into a definitive agreement under which Roche will acquire Mirus Bio Corporation, a privately-owned US company based in Madison, Wisconsin, that focuses on the discovery and development of innovative nucleic acid based technologies, including a proprietary RNAi (Ribonucleic Acid interference) delivery platform.
Eli Lilly and Co and Boehringer Ingelheim have announced that the European Commission has approved the use of Cymbalta (duloxetine) for the treatment of Generalised Anxiety Disorder (GAD).
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Donna T Decosta, MD 7253 Ambassador Rd, Baltimore, MD 21244-2710 Ph: (443) 436-1151 | Donna T Decosta, MD 7253 Ambassador Rd, Baltimore, MD 21244-2710 Ph: (443) 436-1151 |
News Archive
A new way of understanding autistic disorders, incorporating both psychological and biological factors, could lead to the conditions being picked up earlier, research from UNSW has found.
SCIENTISTS at the University of Huddersfield are pioneering the use of a special gel that is ideal for administering medication to young children and others - including the elderly - who have difficulty swallowing pills and capsules. Unlike purely liquid medicines, the gel delays the release of the drug, so that it has maximum effect.
The use of chemotherapy following surgery reduces the risk of death from operable pancreatic cancer by around 30 per cent, says new research published in the British Journal of Cancer.
Roche (Basel) and Mirus Bio Corporation (Madison, WI, USA) announced today that they have entered into a definitive agreement under which Roche will acquire Mirus Bio Corporation, a privately-owned US company based in Madison, Wisconsin, that focuses on the discovery and development of innovative nucleic acid based technologies, including a proprietary RNAi (Ribonucleic Acid interference) delivery platform.
Eli Lilly and Co and Boehringer Ingelheim have announced that the European Commission has approved the use of Cymbalta (duloxetine) for the treatment of Generalised Anxiety Disorder (GAD).
› Verified 4 days ago
Dr. Barun Aryal, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3001 S Hanover St, Dept Of Internal Medicine, Baltimore, MD 21225 Phone: 410-350-3565 Fax: 410-354-0186 | |
Imran Ahmed, D.O Radiology Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St, Dept Of Radiology, Baltimore, MD 21201 Phone: 410-328-3477 | |
Michael Goldman, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 301 Saint Paul Pl, Radiology Dept, Baltimore, MD 21202 Phone: 410-332-9266 Fax: 410-545-4255 | |
Dr. Jeffrey R. Galvin, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St, Dept Of Radiology, Baltimore, MD 21201 Phone: 410-328-3477 | |
Martin Auster, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4940 Eastern Ave, Baltimore, MD 21224 Phone: 410-550-0214 | |
Amy K Pepperney, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 7253 Ambassador Rd, Baltimore, MD 21244 Phone: 443-436-1151 Fax: 443-436-1256 | |
Carolyn Kwon, Radiology Medicare: May Accept Medicare Assignments Practice Location: 4940 Eastern Ave, Baltimore, MD 21224 Phone: 410-550-0100 |